Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
RVMDW | US
0.13
3.02%
Healthcare
Biotechnology
30/06/2024
24/04/2026
4.43
4.25
4.65
4.08
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
642.6%1 month
457.4%3 months
291.3%6 months
286.3%-
-
-
0.05
0.05
-
-
-
-569.47M
-
-
-
-77.52K
-
-
-40.73
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
4.53
Range1M
4.68
Range3M
4.93
Rel. volume
0.22
Price X volume
257.22K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| XOMAP | XOMAP | Biotechnology | 26.125 | 0 | 26.27 | 121.93% | |
| XOMA Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock | XOMAO | Biotechnology | 25.4278 | 0 | -0.44% | 25.57 | 121.93% |
| Vaxxinity Inc. Class A Common Stock | VAXX | Biotechnology | 0 | 0 | -100.00% | n/a | 113.12% |
| SABSW | SABSW | Biotechnology | 0.0185 | 0 | 0.17 | 11.58% | |
| REVBW | REVBW | Biotechnology | 0.0092 | 0 | n/a | 0.00% | |
| Nutriband Inc. Warrant | NTRBW | Biotechnology | 1.17 | 0 | -2.50% | n/a | 1.72% |
| JSPRW | JSPRW | Biotechnology | 0.0155 | 0 | n/a | 2.31% | |
| ICUCW | ICUCW | Biotechnology | 0.0298 | 0 | 49.75% | n/a | -45.50% |
| Humacyte Inc | HUMAW | Biotechnology | 0.0868 | 0 | -1.48% | n/a | -63.37% |
| EyeGate Pharmaceuticals Inc | EYEG | Biotechnology | 35.5287 | 0 | 0.13% | n/a |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
No data | |||||||
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | 0.53 | - |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 291.33 | 72.80 | Riskier |
| Debt to Equity | 0.05 | -1.23 | Expensive |
| Debt to Assets | 0.05 | 0.25 | Cheaper |
| Market Cap | - | 3.66B | - |